IVF Experts Say They Are Closer to Unraveling the Mysteries of Infertility

Scientists are beginning to crack the other half of the fertilization equation

Join Our Community of Science Lovers!

The increasing success of in vitro fertilization (IVF) has come mainly from advances in the way doctors grow and select embryos. When transferred into a woman's womb, however, only a minority of these embryos implant in the lining of the uterus, also known as the endometrium. “The reason,” says Steven L. Young, professor of obstetrics and gynecology at the University of North Carolina at Chapel Hill, “lies primarily with an inability to evaluate if the endometrium is ready for the embryo.” If it is not, embryos will not implant, much like good seed will not grow in bad soil.

Scientists know that the endometrium undergoes dramatic changes during the menstrual cycle and becomes receptive to embryo implantation during only a short period a few days after ovulation. They have yet to find a reliable way to figure out when and if a patient's uterus is ready to accept a hard-won embryo.

Ongoing studies are just starting to provide some answers. Linda Giudice and her colleagues at the University of California, San Francisco, have used genomic analysis to identify a group of genes that turn on and off at different phases of the menstrual cycle. Nicholas S. Macklon, professor of obstetrics and gynecology at the University of Southampton in England, has found that the protein content of endometrial fluid changes depending on whether it is in a receptive or nonreceptive stage. If validated in clinical trials, the finding might lead to the development of a laboratory test that could determine on the spot if a patient is ready for embryo transfer.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

Such tests and treatments are still several years away. But just as the challenges ahead are great, so are the potential rewards. If researchers can determine the molecular processes that predict when an embryo can implant, Macklon notes, they may transform the diagnosis and treatment of infertility.

COMMENT ATScientificAmerican.com/sep2012

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American